BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20302018)

  • 21. [Yeast prions, mammalian amyloidoses, and the problem of proteomic networks].
    Galkin AP; Mironova LN; Zhuravleva GA; Inge-Vechtomov SG
    Genetika; 2006 Nov; 42(11):1558-70. PubMed ID: 17163073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prion species barrier between the closely related yeast proteins is detected despite coaggregation.
    Chen B; Newnam GP; Chernoff YO
    Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2791-6. PubMed ID: 17296932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conformation preserved in a weak-to-strong or strong-to-weak [PSI+] conversion during transmission to Sup35 prion variants.
    Crist CG; Kurahashi H; Nakayashiki T; Nakamura Y
    Biochimie; 2006 May; 88(5):485-96. PubMed ID: 16364534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extraction and denaturing gel electrophoretic methodology for the analysis of yeast proteins.
    O'Callaghan KJ; Byrne LJ; Tuite MF
    Methods Mol Biol; 2005; 308():357-73. PubMed ID: 16082048
    [No Abstract]   [Full Text] [Related]  

  • 25. Hsp104 as a key modulator of prion-mediated oxidative stress in Saccharomyces cerevisiae.
    Singh K; Saleh AA; Bhadra AK; Roy I
    Biochem J; 2013 Sep; 454(2):217-25. PubMed ID: 23746301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of prion protein binding proteins by combined use of far-Western immunoblotting, two dimensional gel electrophoresis and mass spectrometry.
    Strom A; Diecke S; Hunsmann G; Stuke AW
    Proteomics; 2006 Jan; 6(1):26-34. PubMed ID: 16294306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Importance of the Hsp70 ATPase domain in yeast prion propagation.
    Loovers HM; Guinan E; Jones GW
    Genetics; 2007 Feb; 175(2):621-30. PubMed ID: 17151238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Psi(+)] prion generation in yeast: characterization of the 'strain' difference.
    Kochneva-Pervukhova NV; Chechenova MB; Valouev IA; Kushnirov VV; Smirnov VN; Ter-Avanesyan MD
    Yeast; 2001 Apr; 18(6):489-97. PubMed ID: 11284005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A region within the C-terminal domain of Ure2p is shown to interact with the molecular chaperone Ssa1p by the use of cross-linkers and mass spectrometry.
    Redeker V; Bonnefoy J; Le Caer JP; Pemberton S; Laprévote O; Melki R
    FEBS J; 2010 Dec; 277(24):5112-23. PubMed ID: 21078122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A yeast prion, Mod5, promotes acquired drug resistance and cell survival under environmental stress.
    Suzuki G; Shimazu N; Tanaka M
    Science; 2012 Apr; 336(6079):355-9. PubMed ID: 22517861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Qualitative and quantitative multiplexed proteomic analysis of complex yeast protein fractions that modulate the assembly of the yeast prion Sup35p.
    Redeker V; Hughes C; Savistchenko J; Vissers JP; Melki R
    PLoS One; 2011; 6(9):e23659. PubMed ID: 21931608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization and enzymatic degradation of Sup35NM, a yeast prion-like protein.
    Chen CY; Rojanatavorn K; Clark AC; Shih JC
    Protein Sci; 2005 Sep; 14(9):2228-35. PubMed ID: 16081647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of amyloid aggregates using agarose gel electrophoresis.
    Bagriantsev SN; Kushnirov VV; Liebman SW
    Methods Enzymol; 2006; 412():33-48. PubMed ID: 17046650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and Analysis of Prion and Amyloid Aggregates from Yeast Cells.
    Kryndushkin D; Pripuzova N; Shewmaker FP
    Cold Spring Harb Protoc; 2017 Feb; 2017(2):. PubMed ID: 28148850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactome analysis of yeast glutathione peroxidase 3.
    Lee PY; Bae KH; Kho CW; Kang S; Lee DH; Cho S; Kang S; Lee SC; Park BC; Park SG
    J Microbiol Biotechnol; 2008 Aug; 18(8):1364-7. PubMed ID: 18756095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomic analysis of a distilling strain of Saccharomyces cerevisiae during industrial grain fermentation.
    Hansen R; Pearson SY; Brosnan JM; Meaden PG; Jamieson DJ
    Appl Microbiol Biotechnol; 2006 Aug; 72(1):116-125. PubMed ID: 16820951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative proteome analysis of Saccharomyces cerevisiae: a global overview of in vivo targets of the yeast activator protein 1.
    Jun H; Kieselbach T; Jönsson LJ
    BMC Genomics; 2012 Jun; 13():230. PubMed ID: 22681880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An improved method for whole protein extraction from yeast Saccharomyces cerevisiae.
    Zhang T; Lei J; Yang H; Xu K; Wang R; Zhang Z
    Yeast; 2011 Nov; 28(11):795-8. PubMed ID: 21972073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Capillary HPLC-ICP MS mapping of selenocompounds in spots obtained from the 2-D gel electrophoresis of the water-soluble protein fraction of selenized yeast.
    Tastet L; Schaumlöffel D; Bouyssiere B; Lobinski R
    Anal Bioanal Chem; 2006 Jul; 385(5):948-53. PubMed ID: 16791577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of proteins associated with polyglutamine aggregates: a novel approach towards isolation of aggregates from protein conformation disorders.
    Wang Y; Meriin AB; Costello CE; Sherman MY
    Prion; 2007; 1(2):128-35. PubMed ID: 19164926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.